Oct 27, 2020
Bayer Set to Fork Over USD 4 Billion for AskBio’s Gene Therapies Germany-based Bayer is set to acquire North Carolina-based Asklepios BioPharmaceutical (AskBio) with motives to get its hands on its gene therapies. Bayer will pay USD 2 billion in upfront payment in exchange for AskBio's AAV-based gene th...
Read More...
Aug 13, 2024
Every year during Breast Cancer Awareness Month, numerous campaigns aim to raise awareness about breast cancer, its symptoms, early diagnosis, and treatment options. Significant progress has been made in managing breast cancer, assessing its risks, and treating it through a combination of surgery, radiation, and ot...
Read More...
Aug 08, 2024
October, a month awash in pink, stands as a global testament to Breast Cancer Awareness Month. Pink ribbons flutter in the breeze, pink tee-shirts fill the streets, and pink banners drape buildings. This vibrant display of pink is more than a color; it’s a unified call to action, dedicating a month to raising aware...
Read More...
Oct 22, 2020
GSK eyes robust immune response from RSV vaccine Cold viruses mostly do not get much attention in terms of R&D. They usually make humans feel miserable for a few days, and later than clear up. However, some cold viruses can hit vulnerable people much harder, which leads to pneumonia and hospitalizations. Th...
Read More...
Oct 21, 2020
In today’s healthcare system quality care, rising cost, and satisfaction are significant issues that need to be addressed to improve the experience of patients. To provide an alternative to these issues a new health-care model called Value-based healthcare or VBC is gaining significant attention from industry leade...
Read More...
Oct 20, 2020
Full FDA Approval for Venclexta Combinations for Acute Myeloid Leukemia The US FDA has granted its full approval to Venclexta (venetoclax) for newly diagnosed acute myeloid leukemia (AML) in adults 75 years or older who are unfit for intensive induction chemotherapies. The approval is based on the res...
Read More...
Oct 19, 2020
Neurodegenerative diseases affect millions of people worldwide. And with the world demographics getting older, it is apt to foretell that the burden of neurodegenerative disorders is expected to mount. With advances in medical technology, the life expectancy of people has drastically increased, reeling people to an...
Read More...
Aug 14, 2024
Breast cancer is the most common form of cancer in women. Each year, it affects over 2 million women globally and is the most significant cause of death among women. Among the many types of breast cancer, a particularly formidable foe is Triple-negative breast cancer (TNBC), which accounts for 10-20% of all cases. ...
Read More...
Oct 15, 2020
Cyclerion flunks sickle cell test, prompting pivot to CNS disease Cyclerion Therapeutics has terminated the development of olinciguat in sickle cell disease after getting a look at data from a phase 2 trial. The setback caused Cyclerion to switch its focus to IW-6463 and to treat central nervous system diseases....
Read More...
Oct 14, 2020
The disparity can be any type of imbalance or inequality that brings various types of variation in society, based on age, education, income, gender, etc. In a society, a wide number of disparities exist; disparities in wealth, living styles, resources, and several different aspects of society. However, the disparit...
Read More...